BioCryst Pharmaceuticals Inc
€7.291
EUR
Last updated on --.
24h volume3.00M
24h highest7.3384 EUR
24h lowest6.9792 EUR
24h Price movement+2.35%
BCRX recent prices
24 Hours
+2.35%+€0.16756
30 days
-4.66%-€0.35661
60 days
-11.20%-€0.89797
90 days
+7.41%+€0.50269
Key data
Previous close7.1236 EUR
Market cap1.91B EUR
Volume3.00M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.5467 EUR
Net income (FY)-393.54M EUR
Revenue (FY)761.10M EUR
Last report date6 May 2026
About BioCryst Pharmaceuticals Inc
HeadquartersDURHAM
Employees (FY)435.00
Revenue per employee (FY)1.75M EUR
Net income per employee (FY)-904.70K EUR
Listed onNasdaq
BCRX conversion tables
 |  |
|---|---|
| 0.5 BCRX | 3.645 EUR |
| 1 BCRX | 7.291 EUR |
| 5 BCRX | 36.45 EUR |
| 10 BCRX | 72.91 EUR |
| |
|---|---|
| 0.5 EUR | 0.068576 BCRX |
| 1 EUR | 0.13715 BCRX |
| 5 EUR | 0.68576 BCRX |
| 10 EUR | 1.371 BCRX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BCRX is trading at €7.291, +2.35% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BCRX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BCRX is currently trading at €7.291, +2.35% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BCRX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BCRX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BCRX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BCRX's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
BioCryst Pharmaceuticals Inc's market cap is currently 1.91B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume3.00M
24h highest7.3384 EUR
24h lowest6.9792 EUR
24h Price movement+2.35%
Start trade with BCRX Perpetual
Sign up to trade